Advertisement
Singapore markets closed
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • Dow

    37,753.31
    -45.66 (-0.12%)
     
  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     
  • Bitcoin USD

    61,685.29
    -1,432.70 (-2.27%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,866.99
    +19.00 (+0.24%)
     
  • Gold

    2,394.40
    +6.00 (+0.25%)
     
  • Crude Oil

    81.79
    -0.90 (-1.09%)
     
  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     
  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    +35.97 (+0.50%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Eli Lilly (LLY) is a Top Dividend Stock Right Now: Should You Buy?

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Eli Lilly in Focus

Eli Lilly (LLY) is headquartered in Indianapolis, and is in the Medical sector. The stock has seen a price change of -6.38% since the start of the year. The drugmaker is currently shelling out a dividend of $0.64 per share, with a dividend yield of 2.38%. This compares to the Large Cap Pharmaceuticals industry's yield of 3.06% and the S&P 500's yield of 1.87%.

ADVERTISEMENT

In terms of dividend growth, the company's current annualized dividend of $2.58 is up 14.7% from last year. Over the last 5 years, Eli Lilly has increased its dividend 5 times on a year-over-year basis for an average annual increase of 4.89%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Lilly's current payout ratio is 46%. This means it paid out 46% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, LLY expects solid earnings growth. The Zacks Consensus Estimate for 2019 is $5.66 per share, representing a year-over-year earnings growth rate of 1.98%.

Bottom Line

From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. However, not all companies offer a quarterly payout.

High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, LLY is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eli Lilly and Company (LLY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research